MetaLead Secures CHF 1M to advance treatment for Wilson's disease
Summary
Zurich-based startup metaLead Therapeutics has raised CHF 1M from the UZH Life Sciences Fund to accelerate the development of a new treatment for Wilson disease, a rare condition caused by copper buildup in the body. The company is using a novel peptide-based platform to improve metal-binding therapies.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected